J Clin Oncol

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.

Tobiasson M, Pandzic T, Illman J, ..., Dybedal I, Hellström-Lindberg E

J Clin Oncol 42 (12) 1378-1390 [2024-04-20; online 2024-01-17]

First-in-human (FIH) phase I dose escalation study (part A) of the first oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ) roginolisib in patients with advanced cancer and dose confirmation in uveal melanoma (part B).

Di Giacomo AM, Santangelo F, Amato G, ..., Evans TRJ, Maio M

J Clin Oncol 41 (16_suppl) 3110-3110 [2023-06-01; online 2023-06-01]

Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial).

Olofsson Bagge R, Nelson A, Shafazand A, ..., Ny L, Lindnér P

J Clin Oncol 41 (16) 3042-3050 [2023-06-01; online 2023-03-20]

Clonal Hematopoiesis and Risk of Incident Lung Cancer.

Tian R, Wiley B, Liu J, ..., Bolton KL, Cao Y

J Clin Oncol 41 (7) 1423-1433 [2023-03-01; online 2022-12-08]

Abhishek Niroula DDLS Fellow

Integrating the "Immunome" in the Stratification of Myelodysplastic Syndromes and Future Clinical Trial Design.

Winter S, Shoaie S, Kordasti S, Platzbecker U

J Clin Oncol 38 (15) 1723-1735 [2020-05-20; online 2020-02-14]

Saeed Shoaie SciLifeLab Fellow

Plasma proteomic analyses and treatment predictive biomarker candidates in melanoma patients receiving immune checkpoint blockade or targeted therapy.

Eriksson H, Babacic H, Lehtio J, Pernemalm M

J Clin Oncol 37 (15_suppl) 9574-9574 [2019-05-20; online 2019-05-20]

Dissecting genetic heterogeneity in stage III cutaneous malignant melanoma with spatially resolved transcriptomics.

Eriksson H, Thrane K, Maaskola J, Hansson J, Lundeberg J

J Clin Oncol 36 (15_suppl) e21587-e21587 [2018-05-20; online 2018-05-20]

Associations of PD-1 and PD-L1 expression with mismatch repair status and prognosis in chemoradiotherapy-naïve esophageal and gastric adenocarcinoma.

Svensson M, Borg D, Zhang C, ..., Leandersson K, Jirstrom K

J Clin Oncol 36 (4_suppl) 9-9 [2018-02-01; online 2018-02-01]

A translational effort to identify prognostic and predictive biomarkers in pancreatic cancer among RBM3-regulated genes.

Olsson Hau S, Karnevi E, Lundgren S, ..., Gallagher WM, Jirstrom K

J Clin Oncol 36 (4_suppl) 305-305 [2018-02-01; online 2018-02-01]